| (S)-2-(6-bromobenzo[d][1,3]dioxol-5-yl)-N-(4-cyanophenyl)-1-(1-cyclohexylethyl)-1H-benzo[d]imidazole-5-carboxamide |
(S)-2-(6-溴苯并[D][1,3]二氧杂环戊烯-5-基)-N-(4-氰基苯基)-1-(1-环己基乙基)-1H-苯并[D]咪唑-5-甲酰胺 |
2100284-59-9 |
| LSD1-IN-1 |
N1-(反式-2-苯基环丙基)环己烷-1,4-二胺二盐酸盐 |
1431326-61-2 |
| XMD17 109 |
XMD17 109 |
1435488-37-1 |
| 3--Phenyl-N-(2,2,2-trichloro-1-((((4-chlorophenyl)amino)carbonothioyl)amino)ethyl)acrylamide |
(2E)-3-苯基-N-[2,2,2-三氯-1-[[[(4-氯苯基)氨基]硫代甲酰基]氨基]乙基]-2-丙烯酰胺 |
1164470-53-4 |
| CH5132799 |
CH5132799 |
1007207-67-1 |
| JZL 184 |
JZL-184 |
1101854-58-3 |
| LY2584702 |
LY-2584702 |
1082949-67-4 |
| Wnt Agonist |
WNT AGONIST 1 (CID11210285 盐酸盐) |
853220-52-7 |
| Danirixin |
GSK1325756 |
954126-98-8 |
| LY2409881 trihydrochloride |
IKK2抑制剂（LY2409881） |
946518-60-1 |
| SCH772984 |
(R)-1-(2--2-氧(4-(4-(嘧啶-2-基)苯基)对二氮己环-1-基)乙基)-N-(3-(吡啶-4-基)-1H--5INDAZOL-基)吡咯烷-3-甲酰胺 |
942183-80-4 |
| PACRITINIB |
帕克替尼 |
937272-79-2 |
| Ibrutinib |
依鲁替尼 |
936563-96-1 |
| 5-Chloro-N2-[(1S)-1-(5-fluoro-2-pyrimidinyl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamine |
5-氯-N2-[(1S)-1-(5-氟-2-嘧啶基)乙基]-N4-(5-甲基-1H-吡唑-3-基)-2,4-嘧啶二胺 |
935666-88-9 |
| Mycro3 |
944547-46-0 |
944547-46-0 |
| N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide |
N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 |
936091-14-4 |
| SAR245409 |
VOXTALISIB |
934493-76-2 |
| PLX4032 |
维罗非尼 |
918504-65-1 |
| Simeprevir |
司美匹韦 |
923604-59-5 |
| SLx-2119 |
2-[3-[4-[(1H-吲唑-5-基)氨基]喹唑啉-2-基]苯氧基]-N-异丙基乙酰胺 |
911417-87-3 |
